APAS Independence’s CE mark certification

APAS Independence will soon be perfectly suited to the EU market with CE Mark self-certification and the latest…

Winner of 2019 Good Design Awards

The APAS Independence wins the Good Design Award Best in Class accolade in the Medical and Scientific category.

APAS Independent Poster at ASM Microbe

Dr Glen Hansen's Poster on Intelligent Automation presented at the American Society of Microbiology (ASM) Microbe in…

APAS® Independence receives FDA Clearance

We are pleased to announce that the APAS® Independence instrument with Urine AM has received FDA 510(k) clearance.

MRSA Trials Commence

The MRSA trial is under way in Melbourne following work with European company Labor Dr Wisplinghoff in Germany.

US FDA 510(k) Submitted For the APAS® Independence

We are pleased to announce that a 510(k) application with the United States Food and Drug Administration (FDA) has been…

First Placement of APAS Independence in US Lab

Clever Culture Systems AG (CCS) is pleased to announce that it has placed the first APAS® Independence instrument into…

World’s first APAS Purchased by St Vincent’s Hospital Melbourne

Clever Culture Systems, a joint venture between Australian company LBT Innovations Limited (LBT) and Swiss company…

Clever Culture Systems wins silver at the prestigious Medical Design Excellence Awards

The MDEAs, held in New York on 12 June, are the medtech industry’s premier awards, recognizing achievements in medical…

The APAS Independence announced as a finalist for the Medical Design Excellence Awards 2018

Nominated as a finalist in the category of Testing and Diagnostic Products and Systems, LBT Innovations (LBT) and…

APAS Independence heads to Europe

After a successful introduction to the microbiology community at ECCMID 2018 in Madrid, Clever Culture Systems AG has…

APAS Independence performance on show at ECCMID 2018

A poster detailing the performance of the APAS® Independence in a clinical setting was presented by Lisa Brenton of St…

St Vincent’s Hospital Completes APAS Independence In Situ Evaluation

Clever Culture Systems AG and distribution partner, LBT Innovations Limited, have successfully completed an independent…

Comparison Between Digital Image and Traditional Plate Reading Using Urine Cultures

The application of image analysis technologies for the interpretation of microbiological cultures is evolving rapidly.…

New Research Supports the use of APAS in the Clinical Microbiology Laboratory

Clever Culture Systems has received notification that research carried out by LBT Innovations’ Scientific Advisor, John…

US FDA Grants Clearance For LBT’S Automated Plate Assessment System

APAS is a breakthrough artificial Intelligence technology for the automated imaging, image analysis, interpretation and…

Initial Evaluation of an Image Analysis Device for the Screening of Cultures from Clinical Specimens

In recent years there has been an increase in the application of image analysis technologies within the clinical…

Evaluation of an Image Analysis Device (APAS) for Screening Urine Cultures

While advancements have been made in some areas of pathology with diagnostic materials being screened using image analysis technologies, the…

Assessing the Reading of Urine Cultures Using Digital Images

The aim of this preliminary study was to determine if reading digital images of urine culture plates from the Automated…

Automated Reading of Urine Cultures Using a Novel Image Analysis Device

In recent years, the application of image analysis technologies within the clinical laboratory, particularly in the…

Clinical Laboratory Assessment of Urine Cultures by an Image Analysis Device

The Automated Plate Assessment System is a novel device dedicated to screening agar plates. Using image analysis…